Lets not forget that price is really really suppressed between the shorts and market makers. Cytodyn has money for running trials, very promising trials, along with many other great possibilities of partnerships, licensing or an out of left field buyout. I’ve seen companies purchased for billions well before approvals or phase 3 trails. Onward and Upward